Rating Change
Jefferies analysts downgraded Zoetis Inc. (NYSE:ZTS) from Buy to Hold on October 20, 2026.
Jefferies analysts downgraded Zoetis Inc. (NYSE:ZTS) from Buy to Hold on October 20, 2026.

At publication ·
Zoetis Inc. (NYSE:ZTS) · downgrade
At a glance
Jefferies analysts downgraded Zoetis Inc. (NYSE:ZTS) from Buy to Hold on October 20, 2026.
Zoetis Inc. operates in the Healthcare sector. The stock currently trades at $80.04 with a market capitalization of $51.8B. The stock has declined 37.0% over the past 52 weeks.
Analyst downgrades can weigh on a stock in the short term as institutional investors who follow Jefferies's research adjust their positions. However, downgrades also sometimes create buying opportunities if the market overreacts to the rating change. The reasoning behind the downgrade matters more than the rating itself.
Analyst ratings and price targets are one input among many for investment decisions. Historical studies show that consensus analyst recommendations have mixed predictive power on their own, but significant changes in consensus — such as multiple upgrades or downgrades in a short period — can be more meaningful signals.
Among the 10 most recent ratings: 4 Buy, 6 Hold, 0 Sell.
| Date | Firm | Rating | Price Target |
|---|---|---|---|
| Oct 20, 2026 | Jefferies | Hold | N/A |
| Oct 16, 2026 | Goldman Sachs | Neutral | N/A |
| Aug 25, 2026 | TD Cowen | Buy | N/A |
| Aug 20, 2026 | Stifel | Hold | N/A |
| Aug 11, 2026 | Citigroup | Buy | N/A |
Related Tools: Analyst Ratings Dashboard | View ZTS Stock Page
A rating of Hold from Jefferies reflects the analyst's outlook on Zoetis Inc. (NYSE:ZTS). Analyst ratings are one factor investors consider alongside earnings, valuation, and sector trends.
Browse recent upgrades and downgrades on our Analyst Ratings Dashboard or the ZTS forecast page.
Current market data
NYSE · ZTS
$79.72
Up: +$1.45 · +1.85%
Live quote updated
Keep reading